Summary
Two hundred sixty-nine patients suffering from malignant melanoma were sensitized with DNCB acetone solution. The intensity of the skin reaction was normally independent of both the current stage and the further progression of the disease.
This is a preview of subscription content, log in via an institution to check access.
References
Bernheim JL (1974) In: Castermans A, Lejeune F, Matton G (eds) Immunothérapie. Acta Chir Belgica Nr. 2, 265–293
Eilber FR, Nizze A, Morton DL (1975) Sequential evaluation of general immune competence in cancer patients: correlation with clinical course. Cancer 35:660–665
Heid E, Bigel P, Gabriel-Robez O (1975) Données concernant l'éat immunitaire dans le melanoma malin. Ann Dermatol Syph 102:66–68
Loth H, Ehring F (1978) Die Behandlung des Malignen Melanoms mit Dinitrochlorbenzol-Salbe. Hautarzt 29:141–146
Mavligit GM, Guttermann JU, Hersh EM (1976) Effect of BCG (Tine strain) on primary sensitization to 2,4-dinitrochlorbenzene and on established delayed hypersensitivity in human malignant melanoma. J Natl Cancer Inst 57:749–751
Morton DL (1971) In: Morton DL, Holmes EC, Eilber FR, Cood WC (eds) Immunology. Ann Intern Med 74:587–605
Pinsky CM, Domeiri AE, Caron AS, Knapper WH, Oettgen HF (1974) Delayed-hypersensitivity reactions in patients with cancer. Recent Results Cancer Res 47:37–41
Remy W, Russmann B, Stüttgen G (1974) Die Sensibilisierungsrate mit Haptenen bei Tumorträgern. Med Welt 25:1749–1752
Schneider J, Aulepp H, Gartmann H (1976) Histologische und histochemische Untersuchungen an Melanommetastasen unter immunobiologischer und zytostatischer Therapie. Z Hautkr 51:81–90
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ehring, F., Loth, H. DNCB skin test in cases of malignant melanoma. J Cancer Res Clin Oncol 102, 185–187 (1981). https://doi.org/10.1007/BF00410670
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00410670